Back to search

National and Kapodistrian University of Athens

Εκτίμηση και προγνωστική αξία του διαλυτού υποτύπου CD14, πρισεπσίνη, σε κιρρωτικούς ασθενείς

Abstract

dc:description

Background: Bacterial infections in cirrhotic patients remain a challenge. Presepsin has been proposed as a valuable sepsis biomarker. We aimed to assess plasma presepsin levels in uncomplicated cirrhotic patients and to correlate them with liver disease severity and complicating events, defined as documented bacterial infection with or without concomitant portal hypertension-related bleeding, or variceal bleeding without documented bacterial infection, with or without acute kidney injury. Patients and methods: We prospectively evaluated the presepsin levels of 108 consecutive uncomplicated cirrhotic patients with compensated (55, 50.9%) or decompensated (53, 49.1%) cirrhosis. During the follow up, 20 patients were reevaluated for a complicating event. Results: Median baseline presepsin levels of the entire study population were 335.0 pg/mL (IQR 273.8 pg/mL). Patients with decompensated cirrhosis (n=53) exhibited significantly higher baseline levels [median 441.0 pg/mL, IQR 422.5 pg/mL] than patients with compensated cirrhosis (n=55) [median 262.0 pg/mL, IQR 179.0 pg/mL], p <0,001. Patients in the Child-Pugh B/C group (n=37) exhibited significantly higher baseline levels [median 566.0 pg/mL, IQR 356.0 pg/mL] than patients in the Child-Pugh A group (n=71) [median 263.0 pg/mL, IQR 190.0 pg/mL], p <0,001. Patients with MELD score ≥15 (n=18) exhibited significantly higher baseline levels [median 442.5 pg/mL, IQR 365.0 pg/mL] than patients with MELD score <15 (n=90) [median 314.5 pg/mL, IQR 243.8 pg/mL], p <0,001. In complicated cirrhotic patients (n=20), admission levels were remarkably higher [median 943.0 pg/mL, IQR 1593.0 pg/mL] than baseline [median 528.0 pg/mL, IQR 479.8 pg/mL], p <0.001. Patients who developed acute kidney injury (n=10) exhibited significantly higher presepsin levels both at baseline [median 714.0 pg/mL, IQR 637.0 pg/mL] and at admission [median 1616.0 pg/mL, IQR 1470.0 pg/mL], compared to those who did not [baseline median 404.0 pg/mL, baseline IQR 419.0 pg/mL, at admission median 616.5 pg/mL, at admission IQR 664.0 pg/mL], p <0.05. Binary logistic regression analysis was performed to investigate how 1-year mortality can be predicted by baseline presepsin levels. Taking into account patients’ age, sex, liver cirrhosis etiology, Child-Pugh score (≥7 or <7 points), MELD score (≥15 or <15 points) and baseline presepsin levels (≥600 or <600 pg/mL), only MELD score ≥15 points [B (SE) 1.76 (0.90), p <0.05, OR (95%CI) 5.80 (1.00-35.66)] and baseline presepsin levels ≥600 pg/mL [B (SE) 1.77 (0.82), p <0.05, OR (95%CI) 5.88 (1.18-29.27)] were retained in the model for death within the first year (1-year mortality). Baseline presepsin levels, using a cutoff of 607.5 pg/mL, could predict liver disease-related 3-month mortality with 77.8% sensitivity and 86.9% specificity; area under the receiver operating characteristic curve 0.825; 95% confidence interval 0.684-0.967, p <0.01. Conclusions: Plasma presepsin levels are elevated in uncomplicated cirrhotic patients, especially in those with advanced liver disease, and rise further in those complicated by an event defined as documented bacterial infection or variceal bleeding without documented bacterial infection. Baseline presepsin levels in cirrhotic patients could be used as an additional marker, along with the model for end-stage liver disease score, to predict short-term outcomes.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsakiris, Stefanos
  • Τσακίρης, Στέφανος

Subjects

dc:subject × 17

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45755

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsakiris, Stefanos; Τσακίρης, Στέφανος. Εκτίμηση και προγνωστική αξία του διαλυτού υποτύπου CD14, πρισεπσίνη, σε κιρρωτικούς ασθενείς. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/45755